0.9495
price up icon5.50%   0.0495
after-market Dopo l'orario di chiusura: .95 0.0005 +0.05%
loading
Precedente Chiudi:
$0.90
Aprire:
$0.8573
Volume 24 ore:
12,131
Relative Volume:
0.07
Capitalizzazione di mercato:
$34.34M
Reddito:
-
Utile/perdita netta:
$-8.53M
Rapporto P/E:
-3.901
EPS:
-0.2434
Flusso di cassa netto:
$-12.75M
1 W Prestazione:
+15.78%
1M Prestazione:
-1.09%
6M Prestazione:
-15.97%
1 anno Prestazione:
-40.66%
Intervallo 1D:
Value
$0.8573
$0.9495
Intervallo di 1 settimana:
Value
$0.825
$0.9495
Portata 52W:
Value
$0.63
$3.23

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Name
Nome
Estrella Immunopharma Inc
Name
Telefono
(510) 318-9098
Name
Indirizzo
5858 HORTON STREET, SUITE 370, EMERYVILLE
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ESLA's Discussions on Twitter

Confronta ESLA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ESLA
Estrella Immunopharma Inc
0.9495 31.61M 0 -8.53M -12.75M -0.2434
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Estrella Immunopharma Inc Borsa (ESLA) Ultime notizie

pulisher
Jul 24, 2025

Will Estrella Immunopharma Inc. stock benefit from interest rate changesUnstoppable trading performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Estrella Immunopharma Inc. stockMarket-leading growth rates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Estrella Immunopharma Inc. stock priceFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Estrella Immunopharma Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Estrella Immunopharma Inc. a good long term investmentDynamic portfolio growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Estrella Immunopharma Inc. stock attracts strong analyst attentionLong Term Secure Gain Stocks - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

How Estrella Immunopharma Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

how estrella immunopharma inc. stock performs during market volatilityCapital Efficient Investment Tips - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is Estrella Immunopharma Inc. stock overhyped or has real potentialSolid Return Trade Selections - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

What makes Estrella Immunopharma Inc. stock price move sharplyTop Growth Low Risk Stocks - Newser

Jul 16, 2025
pulisher
Jun 07, 2025

Estrella Immunopharma Expands STARLIGHT-1 Trial with New Texas Clinical Site - MSN

Jun 07, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma opens new trial site for cancer therapy By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II Starlight-1 Trial in B-Cell Non-Hodgkin's Lymphoma - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace

Jun 05, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma (ESLA) Expands Clinical Trial with New Sit - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma opens new trial site for cancer therapy - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma Expands STARLIGHT-1 Clinical Trial - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Estrella Immunopharma Announces Activation Of Additional Site For Phase I/Ii Starlight-1 Trial In B-Cell Non-Hodgkin'S Lymphoma - marketscreener.com

Jun 05, 2025
pulisher
Jun 04, 2025

Estrella Immunopharma secures $3.35M in financing to advance clinical triall; shares up - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Analyst Maintains Buy Rating on Estrella Immunopharma (ESLA) | E - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Estrella Immunopharma secures $3.35 million in PIPE financing By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Analyst Maintains Buy Rating on Estrella Immunopharma (ESLA) | ESLA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Estrella Immunopharma (ESLA) Secures $3.35M Through Private Equi - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Estrella Immunopharma secures $3.35 million in PIPE financing - Investing.com Australia

Jun 03, 2025

Estrella Immunopharma Inc Azioni (ESLA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):